ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
12
views
0
references
Top references
cited by
62
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,563
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Hepatitis B e antigen-negative chronic hepatitis B.
Author(s):
D Vassilopoulos
,
Emilia S. Hadziyannis
Publication date:
2001-09-30
Journal:
Hepatology (Baltimore, Md.)
Keywords:
Hepatitis B e Antigens
,
analysis
,
Hepatitis B virus
,
genetics
,
Hepatitis B, Chronic
,
drug therapy
,
etiology
,
immunology
,
Humans
,
Lamivudine
,
therapeutic use
,
Mutation
,
T-Lymphocytes, Cytotoxic
,
Terminology as Topic
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via free article)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
EPA CompTox Chemicals Dashboard
Author and article information
Journal
PubMed ID::
11584355
DOI::
10.1053/jhep.2001.27834
ScienceOpen disciplines:
Chemistry
Keywords:
Hepatitis B e Antigens
,
analysis
,
Hepatitis B virus
,
genetics
,
Hepatitis B, Chronic
,
drug therapy
,
etiology
,
immunology
,
Humans
,
Lamivudine
,
therapeutic use
,
Mutation
,
T-Lymphocytes, Cytotoxic
,
Terminology as Topic
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Hepatitis B e Antigens
,
analysis
,
Hepatitis B virus
,
genetics
,
Hepatitis B, Chronic
,
drug therapy
,
etiology
,
immunology
,
Humans
,
Lamivudine
,
therapeutic use
,
Mutation
,
T-Lymphocytes, Cytotoxic
,
Terminology as Topic
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,563
Hepatitis B Treatment: What We Know Now and What Remains to Be Researched
Authors:
Anna Suk‐Fong Lok
Improved breadth and potency of an HIV-1-neutralizing human single-chain antibody by random mutagenesis and sequential antigen panning.
Authors:
Aran F Labrijn
,
Ponraj Prabakaran
,
Dellaney Rudolph
…
SNP rs7770370 in HLA-DPB1 loci as a major genetic determinant of response to booster hepatitis B vaccination: results of a genome-wide association study.
Authors:
Tzu-Wei Wu
,
Chuen-Fei Chen
,
Sheng-Kai Lai
…
See all similar
Cited by
59
KASL clinical practice guidelines: management of chronic hepatitis B
Authors:
KASL Clinical Practice Guidelines: Management of chronic hepatitis B
Authors:
JSH Guidelines for the Management of Hepatitis B Virus Infection
Authors:
See all cited by